Holen Sie sich die Stockscreener-App
1.0249
5.66%
0.0549
Handel nachbörslich:
2.58
1.5551
+151.73%
Schlusskurs vom Vortag:
$0.97
Offen:
$0.95
24-Stunden-Volumen:
52,926
Relative Volume:
1.30
Marktkapitalisierung:
$6.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$22.68M
KGV:
1.9338
EPS:
0.53
Netto-Cashflow:
$-1.94M
1W Leistung:
+1.48%
1M Leistung:
+7.32%
6M Leistung:
-43.06%
1J Leistung:
-38.26%
1-Tages-Spanne:
$0.9409
$1.04
1-Wochen-Bereich:
$0.92
$1.13
52-Wochen-Spanne:
$0.80
$2.4229
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Firmenname
Pharmacyte Biotech Inc
Sektor
Branche
Telefon
(917) 595.2850
Adresse
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Vergleichen Sie PMCB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.3595 | 1.26B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.58 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.58 | 110.24M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1591 | 351.80M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.25 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Aktie (PMCB) Neueste Nachrichten
PharmaCyte Biotech Inc. Volume Confirms Breakout — Analysts BullishMarket Volume Summary & Capital Efficiency Focused Strategies - thegnnews.com
Is PharmaCyte Biotech Inc. the Top Chart Pick This WeekJuly 2025 Chart Watch & Low Risk High Win Rate Stock Picks - classian.co.kr
Chart overlay techniques for tracking PharmaCyte Biotech Inc.July 2025 Update & Safe Entry Point Alerts - Newser
PharmaCyte Biotech closes $7 million financing to strengthen position - Investing.com
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing | PMCB Stock News - GuruFocus
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing - MarketScreener
PharmaCyte Biotech Inc. stock trend outlook and recovery pathJuly 2025 PostEarnings & Consistent Return Investment Signals - Newser
Is PharmaCyte Biotech Inc. stock ready for a breakout2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
Real time scanner hits for PharmaCyte Biotech Inc. explainedDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
What candlestick patterns are forming on PharmaCyte Biotech Inc.2025 Market Trends & High Accuracy Buy Signal Tips - Newser
Can momentum traders help lift PharmaCyte Biotech Inc.July 2025 Highlights & High Accuracy Investment Entry Signals - Newser
Tools to assess PharmaCyte Biotech Inc.’s risk profileJuly 2025 Recap & Accurate Buy Signal Notifications - Newser
Is PharmaCyte Biotech Inc. stock reversal real or fakeJuly 2025 Fed Impact & Low Drawdown Investment Strategies - Newser
Price action breakdown for PharmaCyte Biotech Inc.July 2025 Price Swings & Verified Momentum Stock Alerts - Newser
Will earnings trigger a reversal in PharmaCyte Biotech Inc.July 2025 Setups & Step-by-Step Trade Execution Guides - Newser
PharmaCyte Biotech Inc. Approaches Support With Recovery in SightJuly 2025 Highlights & Free High Accuracy Swing Entry Alerts - beatles.ru
Analyzing PharmaCyte Biotech Inc. with risk reward ratio charts2025 Volatility Report & Low Drawdown Momentum Trade Ideas - Newser
Backtesting results for PharmaCyte Biotech Inc. trading strategiesJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - Newser
PharmaCyte Biotech Raises $7 Million in Private Placement Financing - AInvest
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Up 1.2% – Should You Buy? - Defense World
PharmaCyte Biotech secures $7 million in private placement financing - Investing.com
PharmaCyte Biotech secures $7 million in private placement financing By Investing.com - Investing.com South Africa
PharmaCyte Biotech Secures $7 Million Private Placement - TipRanks
PharmaCyte's $7M Capital Raise: A Calculated Gamble on Shareholder Value? - AInvest
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors | PMCB Stock News - GuruFocus
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Lelezard
PharmaCyte Biotech Raises $7 Million in Capital Financing - AInvest
How high can PharmaCyte Biotech Inc. stock price go in 2025Quarterly Portfolio Report & Consistent Growth Stock Picks - Newser
Is a relief rally coming for PharmaCyte Biotech Inc. holders2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser
Will PharmaCyte Biotech Inc. stock go up soonWeekly Volume Report & High Yield Equity Trading Tips - Newser
Why PharmaCyte Biotech Inc. stock attracts strong analyst attentionForecast Cut & Safe Capital Allocation Plans - Newser
Can PharmaCyte Biotech Inc. continue delivering strong returnsBreakout Watch & Real-Time Volume Analysis - newsimpact.co.kr
Has PharmaCyte Biotech Inc. found a price floor2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - Newser
PharmaCyte Biotech, Inc. announced that it expects to receive $7 million in funding - MarketScreener
How to forecast PharmaCyte Biotech Inc. trends using time seriesPortfolio Risk Summary & Community Driven Trade Alerts - Newser
Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):